[go: up one dir, main page]

DE69916082D1 - Verbesserte stabilität für injektionslösungen - Google Patents

Verbesserte stabilität für injektionslösungen

Info

Publication number
DE69916082D1
DE69916082D1 DE69916082T DE69916082T DE69916082D1 DE 69916082 D1 DE69916082 D1 DE 69916082D1 DE 69916082 T DE69916082 T DE 69916082T DE 69916082 T DE69916082 T DE 69916082T DE 69916082 D1 DE69916082 D1 DE 69916082D1
Authority
DE
Germany
Prior art keywords
improved stability
injection solutions
injection
solutions
stability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69916082T
Other languages
English (en)
Other versions
DE69916082T2 (de
Inventor
Anna Lundgren
Mats Sundgren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE69916082D1 publication Critical patent/DE69916082D1/de
Application granted granted Critical
Publication of DE69916082T2 publication Critical patent/DE69916082T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A61J1/062—Carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
DE1999616082 1998-09-01 1999-08-24 Verbesserte stabilität für injektionslösungen Expired - Lifetime DE69916082T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802938A SE9802938D0 (sv) 1998-09-01 1998-09-01 Improved stability for injection solutions
PCT/SE1999/001440 WO2000012043A1 (en) 1998-09-01 1999-08-24 Improved stability for injection solutions

Publications (2)

Publication Number Publication Date
DE69916082D1 true DE69916082D1 (de) 2004-05-06
DE69916082T2 DE69916082T2 (de) 2004-10-21

Family

ID=20412436

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1999616082 Expired - Lifetime DE69916082T2 (de) 1998-09-01 1999-08-24 Verbesserte stabilität für injektionslösungen

Country Status (33)

Country Link
US (4) US6576245B1 (de)
EP (1) EP1109526B1 (de)
JP (1) JP2002523184A (de)
KR (1) KR100614162B1 (de)
CN (1) CN1230141C (de)
AR (1) AR033788A1 (de)
AT (1) ATE262882T1 (de)
AU (1) AU754447C (de)
BR (1) BR9913261A (de)
CA (1) CA2340238C (de)
CZ (1) CZ2001743A3 (de)
DE (1) DE69916082T2 (de)
DK (1) DK1109526T3 (de)
EE (1) EE04768B1 (de)
ES (1) ES2217808T3 (de)
HU (1) HUP0104161A3 (de)
ID (1) ID28015A (de)
IL (2) IL141333A0 (de)
IS (1) IS2230B (de)
MY (1) MY120822A (de)
NO (1) NO322292B1 (de)
NZ (1) NZ509985A (de)
PL (1) PL195244B1 (de)
PT (1) PT1109526E (de)
RU (1) RU2224499C2 (de)
SA (1) SA99200573B1 (de)
SE (1) SE9802938D0 (de)
SK (1) SK285474B6 (de)
TR (1) TR200100679T2 (de)
TW (1) TWI228987B (de)
UA (1) UA73282C2 (de)
WO (1) WO2000012043A1 (de)
ZA (1) ZA200101590B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802938D0 (sv) * 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US7129233B2 (en) * 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
US6802828B2 (en) * 2001-11-23 2004-10-12 Duoject Medical Systems, Inc. System for filling and assembling pharmaceutical delivery devices
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201659D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
HUE025683T2 (hu) 2002-12-03 2016-04-28 Pharmacyclics Llc VIIA faktor inhibitor 2-(2-hidroxi-bifenil-3-il)-1H-benzoimidazol-5-karboxamidin-származékok
AU2004206842A1 (en) * 2003-01-14 2004-08-05 Teva Pharmaceutical Industries, Ltd. Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
KR100505557B1 (ko) * 2003-02-10 2005-08-03 조을룡 약병마개 제조용 고무 조성물
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US8476010B2 (en) * 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
US20070166187A1 (en) * 2006-01-18 2007-07-19 Song Jing F Stabilization of paricalcitol using chlorobutyl or chlorinated butyl stoppers
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
ES2944088T3 (es) * 2011-09-27 2023-06-19 Becton Dickinson France Uso de aceite de silicona tratado con plasma como recubrimiento en un dispositivo médico de inyección
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381779A (en) 1981-07-16 1983-05-03 Sterling Drug Inc. Deformable slidable piston to provide self-aspiration in hypodermic cartridge ampoules
ATE84205T1 (de) * 1989-03-28 1993-01-15 Duphar Int Res Vorgefuellte injektionsvorrichtung mit einem fass, das mit einer fluessigen diazepam-formulierung gefuellt ist.
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
SE9103612D0 (sv) 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE9402332D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab Igf-1
SE9501472D0 (sv) * 1995-04-21 1995-04-21 Pharmacia Ab Truncated IGF-I
SA96170106A (ar) 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
TW541316B (en) 1995-12-21 2003-07-11 Astrazeneca Ab Prodrugs of thrombin inhibitors
SE9601556D0 (sv) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
SE9802938D0 (sv) * 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions

Also Published As

Publication number Publication date
CN1230141C (zh) 2005-12-07
EE04768B1 (et) 2007-02-15
NO20011032L (no) 2001-04-30
SE9802938D0 (sv) 1998-09-01
CZ2001743A3 (cs) 2002-01-16
EP1109526B1 (de) 2004-03-31
AU5890399A (en) 2000-03-21
AU754447C (en) 2006-10-19
RU2224499C2 (ru) 2004-02-27
US20030190310A1 (en) 2003-10-09
IL141333A (en) 2006-07-05
TWI228987B (en) 2005-03-11
CN1314804A (zh) 2001-09-26
ES2217808T3 (es) 2004-11-01
HK1035482A1 (en) 2001-11-30
NZ509985A (en) 2002-12-20
EP1109526A1 (de) 2001-06-27
US6660279B2 (en) 2003-12-09
ZA200101590B (en) 2002-05-27
US20040235731A1 (en) 2004-11-25
NO20011032D0 (no) 2001-02-28
PT1109526E (pt) 2004-07-30
SK2822001A3 (en) 2001-08-06
DE69916082T2 (de) 2004-10-21
PL195244B1 (pl) 2007-08-31
CA2340238C (en) 2009-01-06
NO322292B1 (no) 2006-09-11
MY120822A (en) 2005-11-30
HUP0104161A2 (hu) 2002-04-29
SA99200573B1 (ar) 2006-09-20
TR200100679T2 (tr) 2001-07-23
HUP0104161A3 (en) 2002-08-28
ID28015A (id) 2001-05-03
IS2230B (is) 2007-04-15
US6998136B2 (en) 2006-02-14
PL346471A1 (en) 2002-02-11
BR9913261A (pt) 2001-05-22
DK1109526T3 (da) 2004-07-05
UA73282C2 (en) 2005-07-15
KR100614162B1 (ko) 2006-08-25
SA99200573A (ar) 2005-12-03
ATE262882T1 (de) 2004-04-15
AR033788A1 (es) 2004-01-07
AU754447B2 (en) 2002-11-14
JP2002523184A (ja) 2002-07-30
WO2000012043A1 (en) 2000-03-09
KR20010073070A (ko) 2001-07-31
US20060233778A1 (en) 2006-10-19
EE200100131A (et) 2002-06-17
CA2340238A1 (en) 2000-03-09
US6576245B1 (en) 2003-06-10
SK285474B6 (sk) 2007-02-01
IS5845A (is) 2001-02-15
IL141333A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
DE69916082D1 (de) Verbesserte stabilität für injektionslösungen
DE69910363D1 (de) Brennstoffeinspritzung
DE59910742D1 (de) Brennstoffeinspritzanlage
FI980761A0 (fi) Foerfarande i ett paketnaet
ATE351896T1 (de) Brennstoffzusammensetzung
DE69918589D1 (de) Kraftstoffeinspritzsystem
DE69910644D1 (de) Mikrometer
DE69921487D1 (de) Copolyester-binderfasern
FI980293A0 (fi) Multimedia- och multiservicesamtal i ett mobiltelekommunikationsnaet
DE59904243D1 (de) Spritzgiessmaschine
DE69907851D1 (de) Mikrometer
DE59911324D1 (de) Kraftstoffeinspritzsystem
DE69904255D1 (de) Dosiervorrichtung
AT2958U3 (de) Einspritzsystem
DE69920149D1 (de) Verbessertes Einspritzsystem
DE69941197D1 (de) Kraftstoffeinspritzsystem
DE69908863D1 (de) Einspritzventil
DE69906868D1 (de) Kraftstoffeinspritzung
FI980759A0 (fi) Taetningskonstruktion foer suglaodan i en sugvals
ID23196A (id) Gandaran untuk lampuflouresen
DE59903782D1 (de) Kraftstoffeinspritzsystem
DE59908366D1 (de) Kraftstoff-einspritzverfahren
DE59907743D1 (de) Kraftstoffeinspritzsystem
DE69921610D1 (de) Brennstoffeinspritzungsanordnung
ID28246A (id) Karburator

Legal Events

Date Code Title Description
8364 No opposition during term of opposition